Common gene variant doubles dementia risk for men
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
Biology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
FDA clears first blood test for Alzheimer’s detection
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
UW Medicine offers second drug for early Alzheimer’s
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
Next-gen Alzheimer’s drugs extend independent living by months
On Feb. 13, 2025, researchers at Washington University School of Medicine in St. Louis announced a new analysis…
man destined for early Alzheimer’s Survived More Than Twenty Years longer than expected
On Feb. 10, 2025, scientists announced identifying genetic variants that could have helped a man to avoid dementia…
United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
Tufts Research suggests Connection Between Concussions, Viruses, and Alzheimer’s
On Jan. 7, 2025, researchers at Tufts University and Oxford University announced they have uncovered mechanisms connecting trauma…
How fast is your brain ageing? Proteins in blood offer clues
On Dec. 9, 2024, neurologists at Fudan University in Shanghai, China have identified 13 proteins in the blood…
AARP and Leading Research Organizations Announced Risk Factors of Dementia Research Findings
On Nov. 15, 2024, the AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for…
Exposure to certain pollution sources harms children’s learning and memory, USC study shows
On Oct. 31, 2024, a University of Southern California (USC) study involving 8,500 children from across the country…
Neuroscientists revealed Integrated multimodal cell atlas of Alzheimer’s disease
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Biology | Biotechnology | Diagnostics | Disease | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
Study Showed Over 10% of Medicare Beneficiaries Have Diagnoses Indicating Dementia
On Sept. 3, 2024, researchers at NORC at the University of Chicago and George Washington University’s Milken Institute…
the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia
On Jan. 31, 2024, researchers at the National Institutes of Health detected abnormal proteins in the spinal fluid…
‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
Milestones in Parkinson’s
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
NIH researchers identified large genetic changes that contribute to dementia risk
On May 8, 2023, scientists at the National Institutes of Health (NIH) announced that they had identified new…
NIH unveiled new online tool to improve Alzheimer’s clinical trials recruitment
On Jul. 29, 2021, the National Institutes of Health announced it had launched a new online research tool…
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Genetic study of Lewy body dementia supported ties to Alzheimer’s and Parkinson’s diseases
On Feb. 16, 2021, in a study led by National Institutes of Health (NIH) researchers, scientists found that…
NIH researchers linked cases of ALS and FTD to a mutation associated with Huntingtonﾒs disease
On Dec. 4, 2020, researchers at the National Institutes of Health reported that they had made a surprising…
NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s disease
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
Biotechnology | Disease | Neurology | NIH | Therapeutics
NIH augmented large scale study of Alzheimer’s disease biomarkers
On Sept. 10, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…
Albert Einstein College of Medicine received $16 million NIH grant to study cellular process linked to Alzheimerﾒs disease
On Sept. 8, 2020, researchers at Albert Einstein College of Medicine, led by Ana Maria Cuervo, M.D., Ph.D.,…
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…